AXA SA (ENXTPA:CS) entered into an agreement to acquire Maestro Healthcare Technology, Inc. from Oak HC/FT Partners LLC, SV Health Investors, LLC and other shareholders for approximately $160 million on January 22, 2018. The consideration is subject to adjustment to reflect the net debt position of the company at the closing date. After the completion of transaction, Maestro Health will maintain its identity, mission and team, while operating as a wholly-owned subsidiary of AXA. Rob Butler, the current Chief Executive Officer of Maestro Healthcare is intended to stay with and run the business after the transaction. The transaction is subject to customary closing conditions, including the receipt of regulatory approvals. As on February 2, 2018, Federal Trade Commission approved the early termination notice. The transaction is expected to close before the end of first quarter of 2018. Triple Tree acted as the exclusive financial advisor to Maestro Health for this transaction. Tim Aragon, Nicola Evans, Ryan Adrian, Katy Raffensperger, Brittany Wolma, Sam Posnick, Partner David, Hao Wang, Mark Pereira, Robin Samuels, Amy Kett, Carin Carithers, Adrienne Jack, Scott Loughlin, Mohammad Amer, Nathan Salminen, Joseph Vladeck, Sheree Kanner, Matthew Piehl, Isaac Swaiman, Scott McClure, Charles Stones, Lea Ann Fowler, Sierra Russell, Katie Roddy, Jennifer Guzman, Robert Fettman, Kerri Cutry, Brian Curran, Stephenie Gosnell, Michele Harrington and Robert Baldwin of Hogan Lovells acted as legal advisors to AXA.